Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hearing aid reg revisions may be shelved due to de-regulatory political climate.

This article was originally published in The Gray Sheet

Executive Summary

IOL INVESTIGATIONAL DEVICE EXEMPTION REGS ON FAST TRACK as FDA's device rulemaking agenda tacks to the right. As part of an effort to speed publication of rules seen as easing regulatory burdens, FDA is pushing to issue a final rule revoking a special IDE rule for intraocular lenses. The effort reflects calls from Congress and outside groups for relaxation of device regulations.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel